Arbutus Biopharma Corporation (ABUS)
Q2 2019 Results Earnings Conference Call
August 05, 2019, 08:45 AM ET
Company Participants
Pam Murphy - IR Consultant
William Collier - President, CEO
David Hastings - CFO & CAO
Gaston Picchio - Chief Development Officer
Michael Sofia - Chief Scientific Officer
Conference Call Participants
Keay Nakae - Chardan
Jeffrey Tan - B. Riley FBR
Presentation
Operator
Good day, ladies and gentlemen, and welcome to the Arbutus Biopharma Corporation 2019 Second Quarter Financial Results and Corporate Update Conference Call. At this time all participants are in a listen-only mode. Later we